These accomplished investigators each run their own labs, but together they oversee the new Translational Research Laboratory, which facilitates collaboration for clinical and translational cancer researchers across all the disease centers. Their state-of-the-art methods for identifying the genetic variations between tumors help doctors prescribe the new targeted drug most likely to help the patient.
You are using an unsupported browser. Please use the latest version of
Chrome, Firefox, Safari or Edge.
![Triple the impact of your support](https://cdn4.giving.massgeneral.org/assets/2409-MGHFund-FYE-Banner.jpg)
Make your 3x MGH Fund gift now.
During the MGH Fund Triple Match Challenge your gift to the MGH Fund will go 3x as far, now until September 30.
Time left to triple your impact:
![The one hundred honoree: Leif Ellisen, MD, PhD and A. John Iafrate, MD, PhD](https://cdn4.giving.massgeneral.org/assets/leif-ellisen-md-phd-and-a-john-iafrate-md-phd-1.jpg)